A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Denise A Yardley, M.D.
SCRI Development Innovations, LLC
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
70 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- San Juan Hospital
San Juan, Puerto Rico
- Northeast Alabama Regional Medical Center
Anniston, Alabama, United States
- Cancer Center of Huntsville
Huntsville, Alabama, United States
- Clearview Cancer Institute
Huntsville, Alabama, United States
- University of Southern Alabama
Mobile, Alabama, United States
- Northeast Arkansas Clinic
Jonesboro, Arkansas, United States
- Wilshire Oncology Medical Group
La Verne, California, United States
- New Hope Cancer and Research Institute
Pomona, California, United States
- Eastern Connecticut Hematology Oncology
Norwich, Connecticut, United States
- Aventura Medical Center
Aventura, Florida, United States
- Lynn Cancer Institute
Boca Raton, Florida, United States
- Florida Cancer Care
Davie, Florida, United States
- Holy Cross Hospital
Fort Lauderdale, Florida, United States
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Memorial Regional Cancer Center
Hollywood, Florida, United States
- Integrated Community Oncology Network
Jacksonville, Florida, United States
- Watson Clinic Center for Cancer Care and Research
Lakeland, Florida, United States
- Space Coast Medical Associates
Titusville, Florida, United States
- Emory/winship Cancer Institute
Atlanta, Georgia, United States
- Piedmont Healthcare
Atlanta, Georgia, United States
- Augusta Oncology Associates
Augusta, Georgia, United States
- Medical College of Georgia Cancer Specialists
Augusta, Georgia, United States
- Medical Oncology Associates of Augusta
Augusta, Georgia, United States
- Northeast Georgia Medical Center
Gainesville, Georgia, United States
- Suburban Hem Onc
Lawrenceville, Georgia, United States
- Mid-Illinois Hematology & Oncology
Normal, Illinois, United States
- Hematology Oncology of the North Shore
Skokie, Illinois, United States
- Oncology Hematology Associates of Sw Indiana
Evansville, Indiana, United States
- Hematology Oncology of Indiana
Indianapolis, Indiana, United States
- Providence Medical Group
Terre Haute, Indiana, United States
- Kansas City Cancer Centers
Overland Park, Kansas, United States
- Cotton O'Neil Cancer Center
Topeka, Kansas, United States
- Consultants in Blood Disorders and Cancer
Louisville, Kentucky, United States
- Baton Rouge General Medical Center
Baton Rouge, Louisiana, United States
- Mercy Hospital
Portland, Maine, United States
- Weinberg Cancer Institute at Franklin Square
Baltimore, Maryland, United States
- Center for Cancer and Blood Disorders
Bethesda, Maryland, United States
- Fallon Clinic
Worcester, Massachusetts, United States
- Grand Rapids Clinical Oncology Program
Grand Rapids, Michigan, United States
- Fairview Medical Oncology Clinic
Edina, Minnesota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2008
- Primary completion
- 31 Dec 2015
- Completion
- 30 Nov 2016
- Last update posted
- 2 Jul 2017
- Registered enrollment
- 614
- Registry id
- NCT00789581
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.